Loncar Cancer Immunotherapy Etf Buy Hold or Sell Recommendation
| CNCR Etf | USD 14.76 0.27 1.80% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Loncar Cancer Immunotherapy is 'Hold'. Macroaxis provides Loncar Cancer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CNCR positions. The advice algorithm takes into account all of Loncar Cancer's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Loncar Cancer's buy or sell advice are summarized below:
Real Value 13.82 | Hype Value 14.76 | Market Value 14.76 | Naive Value 14.6 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Loncar Cancer Immunotherapy given historical horizon and risk tolerance towards Loncar Cancer. When Macroaxis issues a 'buy' or 'sell' recommendation for Loncar Cancer Immunotherapy, the advice is generated through an automated system that utilizes algorithms and statistical models.
Loncar |
Execute Loncar Cancer Buy or Sell Advice
The Loncar recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Loncar Cancer Immunotherapy. Macroaxis does not own or have any residual interests in Loncar Cancer Immunotherapy or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Loncar Cancer's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details |
Loncar Cancer Trading Alerts and Improvement Suggestions
| Latest headline from news.google.com: Long Term Investment Analysis - Stock Traders Daily | |
| Loncar Cancer Immuno created five year return of -5.0% | |
| This fund holds 99.87% of its assets under management (AUM) in equities |
Loncar Cancer Returns Distribution Density
The distribution of Loncar Cancer's historical returns is an attempt to chart the uncertainty of Loncar Cancer's future price movements. The chart of the probability distribution of Loncar Cancer daily returns describes the distribution of returns around its average expected value. We use Loncar Cancer Immunotherapy price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Loncar Cancer returns is essential to provide solid investment advice for Loncar Cancer.
| Mean Return | 0.11 | Value At Risk | -3.47 | Potential Upside | 3.65 | Standard Deviation | 2.41 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Loncar Cancer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Loncar Cancer Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Loncar Cancer or Loncar Investments sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Loncar Cancer's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Loncar etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.02 | |
β | Beta against NYSE Composite | 2.38 | |
σ | Overall volatility | 2.40 | |
Ir | Information ratio | 0.02 |
Loncar Cancer Volatility Alert
Loncar Cancer Immunotherapy currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of -0.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Loncar Cancer's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Loncar Cancer's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Loncar Cancer Fundamentals Vs Peers
Comparing Loncar Cancer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Loncar Cancer's direct or indirect competition across all of the common fundamentals between Loncar Cancer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Loncar Cancer or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Loncar Cancer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Loncar Cancer by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Loncar Cancer to competition |
| Fundamentals | Loncar Cancer | Peer Average |
| Price To Earning | 24.63 X | 3.15 X |
| Price To Book | 1.99 X | 0.39 X |
| Price To Sales | 1.24 X | 0.33 X |
| Beta | 0.89 | |
| One Year Return | 16.60 % | (0.97) % |
| Three Year Return | (19.80) % | 3.23 % |
| Five Year Return | (4.70) % | 1.12 % |
| Net Asset | 20.52 M | 2.29 B |
| Last Dividend Paid | 0.35 | 0.14 |
| Equity Positions Weight | 99.87 % | 52.82 % |
Loncar Cancer Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Loncar . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Loncar Cancer Buy or Sell Advice
When is the right time to buy or sell Loncar Cancer Immunotherapy? Buying financial instruments such as Loncar Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Loncar Cancer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Loncar Cancer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Loncar Cancer Immuno information on this page should be used as a complementary analysis to other Loncar Cancer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.